ASK PHARM(SZ:002755)2018-05-11 16:00Financial Performance - The company's operating revenue for Q1 2018 was ¥62,080,526.84, representing a 93.04% increase compared to ¥32,158,666.04 in the same period last year[7]. - The net profit attributable to shareholders was ¥4,587,679.52, a significant turnaround from a loss of ¥3,967,171.22 in the previous year, marking a 215.64% increase[7]. - The basic earnings per share increased to ¥0.05 from a loss of ¥0.04, reflecting a 225.00% improvement[7]. - The company reported a 70.20% increase in cash received from sales of goods and services, totaling ¥86,311,397.22 compared to ¥50,712,658.28 in the same period last year[14]. - The company reported an operating profit of CNY 7,172,789.70, a significant improvement from a loss of CNY 3,978,148.80[34]. - The total comprehensive income for the period was CNY 6,100,436.36, compared to a loss of CNY 3,967,171.22 in the previous year[35]. - The total comprehensive income for the first quarter was CNY 10,982,631.79, compared to a loss of CNY 3,048,483.05 in the previous period[38]. - Basic and diluted earnings per share were both CNY 0.11, an improvement from a loss of CNY 0.03 per share in the same period last year[38]. Cash Flow - The net cash flow from operating activities was -¥5,648,603.00, an 86.71% improvement from -¥42,491,372.36 in the previous year[7]. - Cash inflow from operating activities totaled CNY 91,331,485.55, up from CNY 52,845,997.28 in the previous year, representing a 73% increase[41]. - The net cash flow from investing activities was negative CNY 4,020,814.00, worsening from negative CNY 2,338,437.00 in the previous year[42]. - The company reported a net cash outflow from financing activities of CNY 8,820,000.00, with no cash inflow recorded during the period[42]. - The total cash and cash equivalents decreased by CNY 18,573,519.75 compared to a decrease of CNY 44,829,809.36 in the previous year[42]. Assets and Liabilities - Total assets at the end of the reporting period were ¥833,326,589.01, a decrease of 3.84% from ¥866,574,220.72 at the end of the previous year[7]. - Current assets totaled 696.66 million yuan, down from 731.31 million yuan at the beginning of the period[25]. - The company's cash and cash equivalents were 178.20 million yuan, a decrease from 189.57 million yuan at the beginning of the period[25]. - Total liabilities as of March 31, 2018, were 251.02 million yuan, down from 281.55 million yuan at the beginning of the period[27]. - The equity attributable to shareholders of the parent company was 523.69 million yuan, slightly up from 519.18 million yuan[28]. - The company's total assets amounted to CNY 703,334,567.54, slightly down from CNY 711,603,396.85[31]. - Total liabilities were CNY 210,486,127.91, a decrease from CNY 229,737,589.01 in the previous period[31]. - The equity attributable to shareholders increased to CNY 492,848,439.63 from CNY 481,865,807.84[31]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 14,333[10]. - The net profit attributable to shareholders for the first half of 2018 is expected to increase by 327.94% to 371.67%, with a range of 7.5 million to 8.5 million yuan compared to 2.287 million yuan in the same period of 2017[17]. Market Activity - The company has actively expanded its market, leading to business growth and performance improvement due to the addition of new subsidiaries[17]. Other Information - The company reported no overdue commitments from controlling shareholders or related parties during the reporting period[16]. - There were no non-operating fund occupations by controlling shareholders or related parties during the reporting period[19]. - The first quarter report was not audited[47].